Overview
Efficacy of 0.12% Chlorhexidine Gluconate for Peri-implant Mucositis and Gingivitis
Status:
Completed
Completed
Trial end date:
2013-12-01
2013-12-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
The purpose of this study is to analyze the efficacy of 0.12% chlorhexidine gluconate as a chemical adjuvant for the treatment of peri-implant mucositis in single implants compared with homologous teeth with gingivitis, in a non-surgical treatment protocol with a six-month follow-up.Phase:
Phase 2Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Universidade Federal do Rio Grande do NorteTreatments:
Chlorhexidine
Chlorhexidine gluconate
Pharmaceutical Solutions
Criteria
Inclusion Criteria:- Systemically-healthy partially edentulous patients rehabilitated with functional
dental implants and prostheses for at least 1 year;
- Patients had been diagnosed with peri-implant mucositis, probing depth up to 5 mm,
bleeding on probing and no radiographic evidence of bone loss beyond the first two
threads of the implant;
- Patients had been diagnosed with gingivitis in homologous teeth to implants.
Exclusion Criteria:
- Non-smokers and not in maintenance therapy;
- Periodontal treatment during the last six months;
- Have not used antimicrobial (systemic or topical), anti-inflammatory or
immunosuppressive drugs during the six months preceding the study.